Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
B Zöller, … , X He, B Dahlbäck
B Zöller, … , X He, B Dahlbäck
Published December 1, 1994
Citation Information: J Clin Invest. 1994;94(6):2521-2524. https://doi.org/10.1172/JCI117623.
View: Text | PDF
Research Article Article has an altmetric score of 9

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.

  • Text
  • PDF
Abstract

Resistance to activated protein C (APC) is the most prevalent inherited cause of venous thrombosis. The APC resistance phenotype is associated with a single point mutation in the factor V gene, changing Arg506 in the APC cleavage site to a Gln. We have investigated 50 Swedish families with inherited APC resistance for this mutation and found it to be present in 47 of them. Perfect cosegregation between a low APC ratio and the presence of mutation was seen in 40 families. In seven families, the co-segregation was not perfect as 12 out of 57 APC-resistant family members were found to lack the mutation. Moreover, in three families with APC resistance, the factor V gene mutation was not found, suggesting another still unidentified cause of inherited APC resistance. Of 308 investigated families members, 146 were normal, 144 heterozygotes, and 18 homozygotes for the factor V gene mutation and there were significant differences in thrombosis-free survival curves between these groups. By age 33 yr, 8% of normals, 20% of heterozygotes, and 40% of homozygotes had had manifestation of venous thrombosis.

Authors

B Zöller, P J Svensson, X He, B Dahlbäck

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1991 1988 Total
Citations: 1 1 4 1 2 1 4 3 3 6 3 6 5 3 10 10 3 7 5 9 11 14 15 11 19 16 19 25 40 28 10 1 1 1 298
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (298)

Title and authors Publication Year
Efficacy and safety of anti-Xa direct oral anticoagulants vs. warfarin in patients homozygous for Factor V Leiden and prothrombin G20210A mutations.
Dan O, Pikovsky O, Kerman T, Amar S, Rabinovich A
Journal of thrombosis and thrombolysis 2025
A Rare Presentation of Ascites Secondary to Inferior Vena Cava Thrombosis in a Patient With Factor V Leiden Mutation
Hwang S, Kaur D, Iskander M, Botelho P, Rachna V
Cureus 2024
Laboratory Testing for Activated Protein C Resistance (APCR): An Update.
Favaloro EJ, Mohammed S, Vong R, Pasalic L
Methods in molecular biology (Clifton, N.J.) 2023
Testing for Factor V Leiden (FVL) and Prothrombin G20210A Genetic Variants.
Pajič T
Methods in molecular biology (Clifton, N.J.) 2023
Impaired factor V–related anticoagulant mechanisms and deep vein thrombosis associated with A2086D and W1920R mutations
Shimonishi N, Ogiwara K, Yoshida J, Horie K, Nakajima Y, Furukawa S, Takeyama M, Nogami K
Blood Advances 2023
Association between Polymorphism eNOS4, tPA, Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase and the Occurrence of Legg-Calvé-Perthes Disease.
Matuszewska A, Sygacz O, Matuszewski Ł, Stec S, Grzegorzewski A, Gągała J
Journal of Clinical Medicine 2023
The prognostic role of extended preoperative hypercoagulability work-up in high-risk microsurgical free flaps: a single-center retrospective case series of patients with heterozygotic factor V Leiden thrombophilia.
Falkner F, Thomas B, Aman M, Risse EM, Wittenberg G, Gazyakan E, Harhaus L, Bigdeli AK, Kneser U, Radu CA
BMC surgery 2022
Activated protein C has a regulatory role in factor VIII function
AR Wilhelm, NA Parsons, BJ Samelson-Jones, RJ Davidson, CT Esmon, RM Camire, LA George
Blood 2021
Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications
E Rezus, BI Tamba, MC Badescu, D Popescu, I Bratoiu, C Rezus
International journal of molecular sciences 2021
Genetic risk factors for venous thromboembolism
B Zöller, PJ Svensson, B Dahlbäck, C Lind-Hallden, C Hallden, J Elf
Expert Review of Hematology 2020
Homozygous Factor V Leiden Thrombophilia in a Patient With Histologically Confirmed Thromboangiitis Obliterans
M Mensa, T Dobbs, ZM Jessop, IS Whitaker
Clinical medicine insights. Case reports 2019
The association between activated protein C ratio and Factor V Leiden are gender-dependent
RS Hansen, M Nybo
Clinical Chemistry and Laboratory Medicine 2019
Inferior vena cava syndrome in neonates: An evidence‐based systematic review of the literature
P Tieu, B Paes, A Ahmed, D Matino, A Chan, M Bhatt
Pediatric Blood & Cancer 2019
THE CONTRIBUTION OF CARRIER THE ALLELIC VARIANT G1691A OF THE GENE V OF COAGULATION FACTOR TO THE DEVELOPMENT OF THROMBOTIC COMPLICATIONS DEPENDING ON THE PRESENCE OF CARDIOVASCULAR RISK FACTORS IN INDIVIDUALS WITH SECONDARY LEUKOCYTOSIS, THROMBOCYTOSIS A
OY Mishcheniuk, OM Kostiukevych, LK Benkovska, AN Kravchenko
2019
Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): An updated review
R López-Mejías, S Castañeda, F Genre, S Remuzgo-Martínez, FD Carmona, J Llorca, R Blanco, J Martín, MA González-Gay
Autoimmunity Reviews 2018
Factor V Leiden paradox in a middle-aged Swedish population: A prospective study
B Zöller, O Melander, PJ Svensson, G Engström
Vascular medicine (London, England) 2018
The influence of blood count, cardiovascular risks, inherited thrombophilia and JAK2 V617F burden allele on the type of thrombosis in patients with Ph(-) myeloproliferative neoplasms
I Horvat, A Boban, MR Antolic, R Serventi-Seiwerth, P Roncevic, I Radman, D Sertic, M Vodanovic, D Pulanic, S Basic-Kinda, N Durakovic, S Zupancic-Salek, R Vrhovac, I Aurer, D Nemet, R Zadro, B Labar
Clinical Lymphoma, Myeloma & Leukemia 2018
Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state
JP Wood, LM Kreuziger, PE Ellery, SA Maroney, AE Mast
Blood Advances 2017
Hemostasis and Thrombosis
EJ Favaloro, G Lippi
Hemostasis and Thrombosis 2017
Evaluation of role of FV, FVIII and APLAs in the pathogenesis of APCR in FV Leiden negative DVT patients: a study in India
A Sharma, K Singh, A Biswas, R Ranjan, K Kishor, R Kumar, H Pandey, VK Kamal, R Saxena
Journal of Thrombosis and Thrombolysis 2017
New findings on venous thrombogenesis:
JR Byrnes, AS Wolberg
Hämostaseologie 2016
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders
B Dahlbäck
International Journal of Laboratory Hematology 2016
Identification and functional characterization of a novel F5 mutation (Ala512Val, FV B onn ) associated with activated protein C resistance
B Pezeshkpoor, E Castoldi, A Mahler, D Hanel, J Müller, NS Hamedani, A Biswas, J Oldenburg, A Pavlova
Journal of Thrombosis and Haemostasis 2016
Thrombophilic risk of individuals with rare compound factor V Leiden and prothrombin G20210A polymorphisms: an international case series of 100 individuals
MY Lim, AM Deal, S Kim, MD Musty, J Conard, P Simioni, F Dutrillaux, SS Eid, S Middeldorp, WM Halbmayer, B Boneu, M Moia, S Moll
European Journal of Haematology 2016
Frequency and association of 1691 (G>A) FVL, 20210 (G>A) PT and 677 (C>T) MTHFR with deep vein thrombosis in the population of Bosnia and Herzegovina
A Jusić-Karić, R Terzić, Z Jerkić, A Avdić, M Pođanin
Balkan Journal of Medical Genetics 2016
Principles of Critical Care in Obstetrics
A Gandhi, N Malhotra, J Malhotra, N Gupta, NM Bora
2016
Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case–control study in Indian population
A Sharma, T Bhakuni, R Ranjan, R Kumar, K Kishor, VK Kamal, M Mahapatra, MA Jairajpuri, R Saxena
Journal of Thrombosis and Thrombolysis 2015
Factor V Leiden and Cardiopulmonary Bypass
Victor Uppal, Mark Rosin, Jo-Anne Marcoux, Marnie Olson, Jennifer Bezaire, Gregory Dalshaug
The Journal of Extra-Corporeal Technology 2015
Prevalence of Factor V Genetic Variants Associated With Indian APCR Contributing to Thrombotic Risk
A Sharma, T Bhakuni, A Biswas, R Ranjan, R Kumar, K Kishore, M Mahapatra, MA Jairajpuri, R Saxena
Clinical and Applied Thrombosis/Hemostasis 2015
Novel FV mutation (W1920R, FVNara) associated with serious deep vein thrombosis and more potent APC resistance relative to FVLeiden
K Nogami, K Shinozawa, K Ogiwara, T Matsumoto, K Amano, K Fukutake, M Shima
Blood 2014
Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational study
H Rühl, L Schröder, J Müller, S Sukhitashvili, J Welz, WC Kuhn, J Oldenburg, C Rudlowski, B Pötzsch
PloS one 2014
Profile of prothrombotic factors in Indian children with ischemic stroke
R Konanki, S Gulati, R Saxena, AK Gupta, A Seith, A Kumar, A Saxena, M Kabra, V Kalra, R Lakshmy
Journal of Clinical Neuroscience 2014
Factor V Leiden mutation in women with early recurrent pregnancy loss: a meta-analysis and systematic review of the causal association
C Sergi, TA Jishi, M Walker
Archives of Gynecology and Obstetrics 2014
Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation
U Kjellberg, M Rooijen, K Bremme, M Hellgren
Thrombosis Research 2014
Impact of Hormone-Associated Resistance to Activated Protein C on the Thrombotic Potential of Oral Contraceptives: A Prospective Observational Study
H Rühl, L Schröder, J Müller, S Sukhitashvili, J Welz, WC Kuhn, J Oldenburg, C Rudlowski, B Pötzsch, I Ahrens
PloS one 2014
Correlation between thrombophilia and recurrent pregnancy loss in patients with polycystic ovary syndrome: A comparative study
T Kazerooni, F Ghaffarpasand, N Asadi, Z Dehkhoda, M Dehghankhalili, Y Kazerooni
Journal of the Chinese Medical Association 2013
eLS
YC Chang, YH Yu, LM Chuang
Encyclopedia of Life Sciences 2013
Prevalence of genetic risk factors related with thrombophilia and hypofibrinolysis in patients with osteonecrosis of the femoral head in Poland
J Gagala, M Buraczynska, T Mazurkiewicz, A Ksiazek
BMC musculoskeletal disorders 2013
Spontaneous neonatal arterial thromboembolism: infants at risk, diagnosis, treatment, and outcomes
G Rashish, BA Paes, K Nagel, AK Chan, S Thomas
Blood Coagulation & Fibrinolysis 2013
Multiple presence of prothrombotic risk factors in Croatian children with arterial ischemic stroke and transient ischemic attack
JL Krleža, V Ðuranović, A Bronić, DC Herak, V Mejaški-Bošnjak, R Zadro
Croatian medical journal 2013
Procoagulant Activity in Hemostasis and Thrombosis : Virchowʼs Triad Revisited
AS Wolberg, MM Aleman, K Leiderman, KR Machlus
Anesthesia & Analgesia 2012
Autoimmune diseases and venous thromboembolism: a review of the literature
B Zöller, X Li, J Sundquist, K Sundquist
American Journal of Cardiovascular Disease 2012
Interpreting Results From Factor V Leiden Mutation Analysis: A Cautionary Note
GD Sinclair, MC Poon
Clinical and Applied Thrombosis/Hemostasis 2012
Procoagulant Activity in Hemostasis and Thrombosis: Virchow’s Triad Revisited
AS Wolberg, MM Aleman, K Leiderman, KR Machlus
Anesthesia & Analgesia 2011
Encyclopedia of Life Sciences
B Dahlbäck
Encyclopedia of Life Sciences 2011
Factor V Leiden thrombophilia
JL Kujovich
Genetics in Medicine 2011
Medical history screening for thrombophilic risk: is this adequate?
W Eggert-Kruse, A Ziegler, S Horlbeck, T Strowitzki
Fertility and Sterility 2011
Vascular Behcet and Mutations in Thrombogenic Genes: Methylene Tetrahydrofolate Reductase, Factor V, and Prothrombin
E Dagan, Y Baruch, M Fiorilli, M Rozenbaum, I Rosner, R Gershoni-Baruch
Genetic Testing and Molecular Biomarkers 2011
Epidemiology of Activated Protein C Resistance and Factor V Leiden Mutation in the Mediterranean Region
MM Jadaon
Mediterranean journal of hematology and infectious diseases 2011
Acquired Activated Protein C Resistance, Thrombophilia and Adverse Pregnancy Outcomes: A Study Performed in an Irish Cohort of Pregnant Women
S Sedano-Balbás, M Lyons, B Cleary, M Murray, G Gaffney, M Maher
Journal of Pregnancy 2011
The anticoagulant function of coagulation factor V :
TJ Cramer, AJ Gale
Thrombosis and Haemostasis 2011
The anticoagulant function of coagulation factor V:
TJ Cramer, AJ Gale
Thrombosis and Haemostasis 2011
Impact of smoking during pregnancy on functional coagulation testing
D Dizon-Townson, C Miller, V Momirova, B Sibai, CY Spong, G Wendel, K Wenstrom, P Samuels, S Caritis, Y Sorokin, M Miodovnik, MJ O'Sullivan, D Conway, RJ Wapner, SG Gabbe
American journal of perinatology 2011
APC resistance: biological basis and acquired influences
E Castoldi, J Rosing
Journal of Thrombosis and Haemostasis 2010
Factor V Leiden mutation in Arabs in Kuwait by real-time PCR: different values for different Arabs
AA Dashti, MM Jadaon, HL Lewis
Journal of Human Genetics 2010
Thrombophilia screening – at the right time, for the right patient, with a good reason
M Stegnar
Clinical Chemistry and Laboratory Medicine 2010
Factor V Leiden mutation and pregnancy-related complications
U Kjellberg, M Rooijen, K Bremme, M Hellgren
American Journal of Obstetrics and Gynecology 2010
Factor V Leiden and FII 20210 testing in thromboembolic disorders
T Pajič
Clinical Chemistry and Laboratory Medicine 2010
High Prevalence of Activated Protein C Resistance and Factor V Leiden Mutation in an Arab Population and Patients With Venous Thrombosis in Kuwait
MM Jadaon, AA Dashti, HL Lewis
Diagnostic Molecular Pathology 2010
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method
A Tripodi, M Primignani, L Lemma, V Chantarangkul, A Dell'Era, F Iannuzzi, A Aghemo, PM Mannucci
Hepatology 2010
APCR, factor V gene known and novel SNPs and adverse pregnancy outcomes in an Irish cohort of pregnant women
S Sedano-Balbás, M Lyons, B Cleary, M Murray, G Gaffney, M Maher
BMC pregnancy and childbirth 2010
Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation
MH Bos, RM Camire
Journal of coagulation disorders 2010
Death after liposuction: case report and review of the literature
C Terranova, D Sartore, R Snenghi
Medicine Science and the Law 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
May-Thurner syndrome will be completed?
YD Bast, L Dahin
Thrombosis Research 2009
Massive Pulmonary Embolism Associated With Factor V Leiden, Prothrombin, and Methylenetetrahydrofolate Reductase Gene Mutations in a Young Patient on Oral Contraceptive Pills: A Case Report
KM Charafeddine, RA Mahfouz, GY Ibrahim, AT Taher, JJ Hoballah, AM Taha
Clinical and Applied Thrombosis/Hemostasis 2009
Advances in understanding pathogenic mechanisms of thrombophilic disorders
B Dahlback
Blood 2008
The Factor V Leiden mutation is associated with a higher blood haemoglobin concentration in women below 50 of the Malmö Thrombophilia Study (MATS)
N Isma, T Breslin, B Lindblad, PJ Svensson
Journal of Thrombosis and Thrombolysis 2008
THROMBOPHILIC RISK FACTORS IN PATIENTS WITH CRANIAL AND SPINAL DURAL ARTERIOVENOUS FISTULAE
R Gerlach, M Boehm-Weigert, J Berkefeld, J Duis, A Raabe, V Seifert, G Marquardt
Neurosurgery 2008
Oestrogen treatment of constitutional tall stature in girls: is there a risk of thrombosis or bleeding?
O Rask, KO Nilsson, E Berntorp
Acta Paediatrica 2008
Pulmonary Embolism in Medical Patients: An Autopsy-Based Study
N Kakkar, RK Vasishta
Clinical and Applied Thrombosis/Hemostasis 2008
Medicina dell’età prenatale
AL Borrelli, D Arduini, A Cardone, V Ventruto
2008
Arterial Thrombosis in Mice with Factor V Leiden Mutation
ES Sampram, Y Saad, K Ouriel
Vascular 2008
Combined Thrombophilic Mutations in Women with Unexplained Recurrent Miscarriage
A Sotiriadis, G Vartholomatos, M Pavlou, N Kolaitis, L Dova, T Stefos, E Paraskevaidis, SN Kalantaridou
American Journal of Reproductive Immunology 2007
Risk factors for venous thrombosis in Swedish children and adolescents
O Rask, E Berntorp, R Ljung
Acta Paediatrica 2007
Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis
R Chegeni, B Kazemi, A Hajifathali, AA Pourfathollah, GR Lari
Thrombosis Research 2007
Lower Contribution of Factor V Leiden or G202104 Mutations to Ischemic Stroke in Patients With Clinical Risk Factors: Pair-Matched Case-Control Study
D Eterović, M Titlić, V Čulić, R Zadro, D Primorac
Clinical and Applied Thrombosis/Hemostasis 2007
Utility of the Clinical Practice of Admnistering Thrombophilic Screening and Antithrombotic Prophylaxis with Low-Molecular-Weight Heparin to Healthy Donors Treated with G-Csf for Mobilization of Peripheral Blood Stem Cells
M Martino, F Luise, V Oriana, G Console, T Moscato, C Mammì, G Messina, E Massara, G Irrera, A Piromalli, VT Lombardo, C Laganà, P Lacopino
TUMORI 2007
Factor V Leiden as a Common Genetic Risk Factor for Venous Thromboembolism
MD Horne, DJ McCloskey
Journal of Nursing Scholarship 2006
Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism
ZJ Jun, T Ping, Y Lei, L Li, SY Ming, W Jing
Clinical and Laboratory Haematology 2006
Different Genes and Polymorphisms Affecting High-Density Lipoprotein Cholesterol Levels in Greek Familial Hypercholesterolemia Patients
GV Dedoussis, S Maumus, DM Choumerianou, J Skoumas, C Pitsavos, C Stefanadis, S Visvikis-Siest
Genetic Testing 2006
Henoch–Schonlein purpura: polymorphisms in thrombophilia genes
E Dagan, R Brik, Y Broza, R Gershoni-Baruch
Pediatric Nephrology 2006
Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion
R Behjati, MH Modarressi, M Jeddi-Tehrani, P Dokoohaki, J Ghasemi, AH Zarnani, M Aarabi, T Memariani, M Ghaffari, MA Akhondi
Annals of Hematology 2006
Hereditary thrombophilia
S Khan, JD Dickerman
Thrombosis Journal 2006
Functional single nucleotide polymorphism-based association studies
VE Carlton, JS Ireland, F Useche, M Faham
Human genomics 2006
The Leiden mutation and activated protein C resistance as risk factors for disseminated intravascular coagulation in acutely poisoned patients
Mirosław Prazanowski, Barbara Kur, Małgorzata Barańska, Waldemar Lutz, Bozena Piłacik, Zbigniew Kolaciński
Clinical Toxicology 2006
Henoch–Schonlein purpura: polymorphisms in thrombophilia genes
E Dagan, R Brik, Y Broza, R Gershoni-Baruch
Pediatric Nephrology 2006
Arterial thrombosis associated with heterozygous factor V Leiden disorder, hyperhomocysteinemia, and peripheral arterial disease: Importance of synergistic factors
C Page, LE Rubin, RJ Gusberg, A Dardik
Journal of Vascular Surgery 2005
Detection of the Factor V Leiden Mutation in Iranian Patients with Venous Thrombosis
RC ., BK ., AH ., AP ., GR ., MA ., MT ., YM .
Biotechnology(Faisalabad) 2005
Coagulation Factor V Mutations in Iranian Patients with Venous Thrombosis
AH ., BK ., AP ., GR ., RC .
Pakistan Journal of Biological Sciences 2005
The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study
JA Heit, JL Sobell, H Li, SS Sommer
Journal of Thrombosis and Haemostasis 2005
THE JOHN CHARNLEY AWARD: Heritable Thrombophilia and Development of Thromboembolic Disease after Total Hip Arthroplasty
EA Salvati, AG Valle, GH Westrich, AJ Rana, L Specht, BB Weksler, P Wang, CJ Glueck
Clinical Orthopaedics and Related Research 2005
The Role of Factor V Leiden and Prothrombin G20210a Mutations in Sudden Sensorineural Hearing Loss
K G??r??r, Tuncer, G Eskandari, C ??zcan, M ??nal, C ??zsahinoglu
Otology & Neurotology 2005
The Relationship of the Factor V Leiden Mutation and Pregnancy Outcomes for Mother and Fetus
D Dizon-Townson, C Miller, B Sibai, CY Spong, E Thom, G Wendel, K Wenstrom, P Samuels, MA Cotroneo, A Moawad, Y Sorokin, P Meis, M Miodovnik, MJ O’Sullivan, D Conway, RJ Wapner, SG Gabbe
Obstetrics & Gynecology 2005
THE JOHN CHARNLEY AWARD: Heritable Thrombophilia and Development of Thromboembolic Disease after Total Hip Arthroplasty:
EA Salvati, AG Valle, GH Westrich, AJ Rana, L Specht, BB Weksler, P Wang, CJ Glueck
Clinical Orthopaedics and Related Research 2005
Risk factors for venous thrombosis in Swedish children and adolescents: Venous thrombosis in children and adolescents
O Rask, E Berntorp, R Ljung
Acta Paediatrica 2005
Renin–angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery
H Völzke, V Kleine, DM Robinson, R Grimm, S Hertwig, C Schwahn, L Eckel, R Rettig
International Journal of Cardiology 2005
Risk factors for venous thrombosis in Swedish children and adolescents
O Rask, E Berntorp, R Ljung
Acta paediatrica (Oslo, Norway : 1992) 2005
The multiple faces of the partial thromboplastin time APTT
B Dahlback
Journal of Thrombosis and Haemostasis 2004
Factor V Leiden and Perioperative Risk
BS Donahue
Anesthesia & Analgesia 2004
APC resistance: What have we learned since 1993? / APC-Resistenz: Was haben wir seit 1993 hinzugelernt?
B Dahlbäck
LaboratoriumsMedizin 2004
Prevalence of resistance against activated protein C resulting from factor V leiden is significantly increased in myocardial infarction: Investigation of 507 patients with myocardial infarction
K Middendorf, P Göhring, TY Huehns, D Seidel, G Steinbeck, S Nikol
American Heart Journal 2004
M385T polymorphism in the factor V gene, but not Leiden mutation, is associated with placental abruption in Finnish women
E Jääskeläinen, S Toivonen, EL Romppanen, S Helisalmi, L Keski-Nisula, K Punnonen, S Heinonen
Placenta 2004
Syndrome hémorragique fœtal
JM Jouannic
EMC - Hematologie 2004
Factor V Leiden and Contraception
L Ament
Journal of Midwifery & Women s Health 2004
The Predictability of Factor V Leiden (FV:Q506) Gene Mutation via Clotting-Based Diagnosis of Activated Protein C Resistance
N Sayınalp, IC Haznedaroğlu, S Aksu, Y Büyükaşık, H Göker, H Parlak, OI Özcebe, Ş Kirazlı, SV Dündar, A Gürgey
Clinical and Applied Thrombosis/Hemostasis 2004
THE 2003 MARSHALL R. URIST AWARD PAPER: Genetic Background of Osteonecrosis: Associated with Thrombophilic Mutations?
CG Zalavras, G Vartholomatos, E Dokou, KN Malizos
Clinical Orthopaedics and Related Research® 2004
Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee
A Bjrkman, IM Burtscher, PJ Svensson, A Hillarp, J Besjakov, G Benoni
Archives of Orthopaedic and Trauma Surgery 2004
Factor V Leiden and Prothrombin Gene Mutation: Risk Factors for Osteonecrosis of the Femoral Head in Adults
A Bjrkman, PJ Svensson, A Hillarp, IM Burtscher, A Rnow, G Benoni
Clinical Orthopaedics and Related Research® 2004
Principles of Molecular Pathology
AA Killeen
2004
Airline Chair-Rest Deconditioning: Induction of Immobilisation Thromboemboli?
JE Greenleaf, NJ Rehrer, SR Mohler, DT Quach, DG Evans
Sports Medicine 2004
Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J, Neville C, Rauch J, Busque L, Chang ER, Joseph L, Le Comte M, Subang R, Fortin PR
Thrombosis and haemostasis 2004
The discovery of activated protein C resistance
B Dahlb��ck
Journal of Thrombosis and Haemostasis 2003
Coagulation factor V G allele and HR2 haplotype
H Kostka, T Schwarz, S Schellong, C Mix, E Kuhlisch, T Temelkova-Kurktschiev, E Henkel, C Köhler, S Gehrisch, G Siegert
Blood Coagulation & Fibrinolysis 2003
Hormone therapy and venous thromboembolism
RE Peverill
Best Practice & Research Clinical Endocrinology & Metabolism 2003
Comparison of Standard PCR and the LightCycler® Technique to Determine the Thrombophilic Mutations: An Efficiency and Cost Study
B Schroell-Metzger, M Dicato, M Bosseler, G Berchem
Clinical Chemistry and Laboratory Medicine 2003
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women
G Tans, AH Vlieg, MC Thomassen, J Curvers, RM Bertina, J Rosing, FR Rosendaal
British Journal of Haematology 2003
The Effect of Lupus Anticoagulant in the Second-Generation Assay for Activated Protein C Resistance
BD Ragland, CE Reed, BM Eiland, PH Tichenor, CL Hudson, GA Fritsma, BK Adler, MB Marques
American Journal of Clinical Pathology 2003
Influence of factor V Leiden on the development of neovascularisation secondary to central retinal vein occlusion
C Hvarfner, A Hillarp, J Larsson
The British journal of ophthalmology 2003
Factor V Leiden—the commonest molecular defect in arterial and venous thrombophilia in India
RP Ahmed, PK Gupta, M Kannan, VP Choudhry, R Saxena
Thrombosis Research 2003
Activated protein C resistance (FVLeiden) and thrombosis: factor V mutations causing hypercoagulable states
GA Nicolaes, B Dahlbäck
Hematology/Oncology Clinics of North America 2003
Factor V Leiden: A Review of the Literature
L Ament
The Journal of Perinatal & Neonatal Nursing 2003
Deep veinous thrombosis following uneventful phacoemulsification
T Ong, P Trancos, J Jagger
Journal of Cataract & Refractive Surgery 2003
Increased incidence of thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
R Gerlach, H Yahya, S Rohde, M Böhm, J Berkefeld, I Scharrer, V Seifert, A Raabe
Neurological Research 2003
Genetically Determined Procoagulant States and Heparin Use
RD McBane
Seminars in cardiothoracic and vascular anesthesia 2003
Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation
F Faisel, EL Romppanen, M Hiltunen, S Helisalmi, J Laasanen, K Punnonen, JT Salonen, S Heinonen
European Journal of Human Genetics 2003
Epidémiologie de la thrombose veineuse
J Emmerich
Bulletin de l'Académie nationale de médecine 2003
Risk factors for thromboembolism in teens: when should I test?
AE Sass, EJ Neufeld
Current Opinion in Pediatrics 2002
Thrombophilias and Recurrent Miscarriage
AM Adelberg, JA Kuller
Obstetrical & Gynecological Survey 2002
Response to activated protein C decreases throughout pregnancy
C Benedetto, L Marozio, AM Tavella, V Maula, D Carmignani, A Curti
Acta Obstetricia et Gynecologica Scandinavica 2002
The effect of factor V Leiden carriage on maternal and fetal health
D Bloomenthal, P Dadelszen, R Liston, L Magee, P Tsang
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2002
Facteurs génétiques de risque de thrombose
J Emmerich, M Aiach
Annales de Cardiologie et d Angéiologie 2002
Thrombophlébite cérébrale : étude rétrospective de vingt-sept cas
S Rosenstingl, M Ruivard, E Melon, A Schaeffer, M Gouault-Heilmann
La Revue de Médecine Interne 2002
Importancia de la hipercoagulabilidad en la cirugía de la isquemia crónica de extremidades inferiores
S Cáncer-Pérez, F Acín-García, A Fernández-Heredero, L Benito-Fernández, A Bueno-Bertomeu, J Alfayate-García, JR March-García, AL de Carlos
Angiología 2002
A 9-year retrospective assessment of laboratory testing for activated protein C resistance: evolution of a novel approach to thrombophilia investigations
EJ Favaloro, I Orsag, M Bukuya, D Mcdonald
Pathology 2002
Functional characterization of recombinant FV Hong Kong and FV Cambridge
E Norstrøm, E Thorelli, B Dahlbäck
Blood 2002
Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function
G Kunz, AK Öhlin, A Adami, B Zöller, P Svensson, DA Lane
Blood 2002
Clinical Utility of Factor V Leiden (R506Q) Testing for the Diagnosis and Management of Thromboembolic Disorders
RD Press, KA Bauer, JL Kujovich, JA Heit
Archives of pathology & laboratory medicine 2002
Monocytes, but not endothelial cells, downregulate the anticoagulant activity of activated protein C
M Colucci, AM Stramaglia, E Mascolo, E Napoleone, R Lorenzet, N Semeraro
British Journal of Haematology 2001
G20210A prothrombin gene mutation identified in patients with venous leg ulcers
G Jebeleanu, L Procopciuc
Journal of Cellular and Molecular Medicine 2001
Thrombophilic factors in chronic thromboembolic pulmonary hypertension
CC Colorio, ME Martinuzzo, RR Forastiero, G Pombo, Y Adamczuk, LO Carreras
Blood Coagulation and Fibrinolysis 2001
Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation
C Rintelen, I Pabinger, P Bettelheim, K Lechner, PA Kyrle, P Knobl, B Schneider, C Mannhalter
European Journal of Haematology 2001
Consistent Lowering of Clotting Factors for the Treatment of Acute Cardiovascular Syndromes and Hypercoagulability: A Different Pathophysiological Approach
BR Jaeger, P Goehring, J Schirmer, S Uhrig, P Lohse, E Kreuzer, B Reichart, D Seidel
Therapeutic Apheresis and Dialysis 2001
Investigation and management of heritable thrombophilia
ID Walker, M Greaves, FE Preston
British Journal of Haematology 2001
Anti- and Procoagulant Activities in Factor VII-Deficient Subjects
J Astermark, L Tengborn, U Hedner, E Berntorp
Thrombosis Research 2001
Update on selected inherited venous thrombotic disorders
RS Robetorye, GM Rodgers
American Journal of Hematology 2001
Failure in the Detection of Aberrant mRNA from the Heterozygotic Splice Site Mutant Allele for Protein S in a Patient with Protein S Deficiency
H Iida, M Nakahara, K Komori, M Fujise, M Wakiyama, M Urata, S Kinoshita, H Tsuda, K Sugimachi, N Hamasaki
Thrombosis Research 2001
Major and Potential Prothrombotic Genotypes in a Cohort of Patients With Venous Thromboembolism
ML Varela, YP Adamczuk, RR Forastiero, ME Martinuzzo, GS Cerrato, G Pombo, LO Carreras
Thrombosis Research 2001
Prevalence of the factor V Leiden mutation in human inflammatory bowel disease with different activity
Z Nagy, Á Nagy, O Karádi, M Figler, G Rumi, G Sütő, Á Vincze, A Pár, G Mózsik
Journal of Physiology-Paris 2001
Prevalence and Significance of Thrombophilia in Peripheral Arterial Disease
PJ Burns, DA Mosquera, AW Bradbury
European Journal of Vascular and Endovascular Surgery 2001
The Impact of Factor V Mutation on the Risk for Occlusion in Patients Undergoing Peripheral Vascular Reconstructions
ES Sampram, B Lindblad
European Journal of Vascular and Endovascular Surgery 2001
PREVALENCE OF FACTOR V LEIDEN AND ACTIVATED PROTEIN C RESISTANCE IN CENTRAL RETINAL VEIN OCCLUSION:
TM Johnson, S ELDEFRAWY, WG Hodge, BC Leonard, PJ Kertes, SA Taylor, DP Lillicrap
Retina 2001
Thrombophilia and Obstetrical Outcomes
M Walker, G Smith, M Rodger, J Kingdom
Journal SOGC 2001
Two common genetic thrombotic risk factors: Factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis
A Gurgey, IC Haznedaroglu, T Egesel, Y Buyukask, OI Ozcebe, N Saynalp, SV Dundar, Y Bayraktar
American Journal of Hematology 2001
Normalization of haemoglobin concentration with recombinant erythropoietin has minimal effect on blood haemostasis
AG Christensson, BG Danielson, SR Lethagen
Nephrology Dialysis Transplantation 2001
Laboratory Investigation of Thrombophilia
A Tripodi, PM Mannucci
Clinical chemistry 2001
Combined Factor V Leiden and Prothrombin Genotyping in Patients Presenting With Thromboembolic Episodes
JA Friedline, E Ahmad, D Garcia, D Blue, N Ceniza, JC Mattson, D Crisan
Archives of pathology & laboratory medicine 2001
Genetic analysis of factor V Leiden in a family with history of thrombosis and venous leg ulcers
LM Procopciuc, C Has, C Drugan, G Jebeleanu
Journal of Cellular and Molecular Medicine 2000
Familial thrombophilia and retinal vein occlusion
O Backhouse, L Parapia, I Mahomed, D Lee
Eye 2000
The Role of Natural Anticoagulant Deficiencies and Factor V Leiden in the Development of Idiopathic Portal Vein Thrombosis
T Egesel, Y Büyükaṣk, SV Dündar, A Gürgey, Ṣ Kirazl, Y Bayraktar
Journal of Clinical Gastroenterology 2000
Obstetric Implications of Activated Protein C Resistance and Factor V Leiden Mutation
RB Gherman, TM Goodwin
Obstetrical & Gynecological Survey 2000
Left Brachial Artery Thrombus, Left Axillary Vein Thrombus, and Stroke in a Neonate With Factor V Leiden Mutation
KJ Broxterman, P Mathew, L Chicoine
Journal of Pediatric Hematology/Oncology 2000
Factor V Leiden: the venous thrombotic risk in thrombophilic families
R Lensen, F Rosendaal, JV And, R Bertina
British Journal of Haematology 2000
Thrombophilia in pregnancy
ID Walker
Journal of clinical pathology 2000
Criteria for evaluating evidence that laboratory abnormalities are associated with the development of venous thromboembolism
SM Bates, JS Ginsberg, SE Straus, H Rekers, DL Sackett
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2000
Frequency of Polymorphisms in the B-domain of Factor V Gene in APC-resistant Patients
H Kostka, G Siegert, T Schwarz, S Gehrisch, E Kuhlisch, S Schellong, W Jaross
Thrombosis Research 2000
The Decanucleotide Insertion/Deletion Polymorphism in the Promoter Region of the Coagulation Factor VII Gene and the Risk of Familial Myocardial Infarction
AD Castelnuovo, A D'Orazio, C Amore, A Falanga, MB Donati, L Iacoviello
Thrombosis Research 2000
¿Trombofilia y enfermedad de Perthes?
JM Puigbert, CA Martínez, MA Canyadell, IN Fusté, PV Valentín, JJ Aramburu
Anales de Pediatría 2000
Combined Genetic Defect (Homogeneity for Factor V Leiden and Heterogeneity for Prothrombin G20210A Allele), in a Young Patient, with Recurrent Deep Vein Thrombosis and Serious Postphlebitic Syndrome: A Case Report
H Ioannou, A Eleftheriou, V Nousias, C Basioukas, G Kakosimos, C Batsis, G Vartholomatos, M Mitsis
Angiology 2000
From Molecule to Men
M Zehender, H Just, G Breithardt
2000
Intrauterine Growth Restriction
J Kingdom, P Baker
2000
Proteolytic processing of human coagulation factor IX by plasmin
JA Samis, GD Ramsey, JB Walker, ME Nesheim, AR Giles
Blood 2000
Occlusive Vascular Diseases in Oral Contraceptive Users: Epidemiology, Pathology and Mechanisms
IF Godsland, U Winkler, O Lidegaard, D Crook
Drugs 2000
Leiden mutation in patients with Crohn’s disease
Z Nagy, Á Nagy, O Karádi, M Figler, G Sütö, A Vincze, A Pár, G Mózsik
Inflammopharmacology 1999
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutation
VL Cam-Duchez, S Gandrille, D Tregouet, M Alhenc-Gelas, J Emmerich, JN Fiessinger, JY Borg, M Aiach
British Journal of Haematology 1999
Thrombophilia
MV Huisman, F Rosendaal
Current Opinion in Hematology 1999
Acquired APC resistance and oral contraceptives: differences between two functional tests
J Curvers, MC Thomassen, GA Nicolaes, R Oerle, K Hamulyak, C HEMKER, G Tans, J Rosing
British Journal of Haematology 1999
Pseudohomozygosity for activated protein C resistance is a risk factor for venous thrombosis
G Castaman, A Tosetto, M Ruggeri, F Rodeghiero
British Journal of Haematology 1999
Effects of oral contraceptives on hemostasis and thrombosis
J Rosing, G Tans
American Journal of Obstetrics and Gynecology 1999
Thrombophilia: a genetic predisposition to thrombosis
RA Sacher
Transactions of the American Clinical and Climatological Association 1999
The Effect of Short-Term Cold Exposure on Risk Factors for Cardiovascular Disease
JB Mercer, B Østerud, T Tveita
Thrombosis Research 1999
Expérience d'un laboratoire d'hôpital général en biologie moléculaire
N Profizi, C Poggi, L Chollet
Revue Française des Laboratoires 1999
Thrombosis Involving the Major Veins with Heterozygote Factor V Leiden Mutation as the Only Risk Factor
SL Tokgözoğlu, T Açil, IC Haznedaroglu, K Aytemir, MK Batur
Clinical and Applied Thrombosis/Hemostasis 1999
Mesenteric vein thrombosis due to factor V Leiden gene mutation
M Bergenfeldt, PJ Svensson, A Borgstrom
The British journal of surgery 1999
A possible role for activated protein C resistance in patients with first and second trimester pregnancy failure
J Tal, LM Schliamser, Z Leibovitz, G Ohel, D Attias
Human Reproduction 1999
The Influence of Developmental Haemostasis on the Laboratory Diagnosis and Management of Haemostatic Disorders During Infancy and Childhood
C Male, M Johnston, C Sparling, LA Brooker, M Andrew, P Massicotte
Clinics in Laboratory Medicine 1999
Poor Response to Activated Protein C as a Prominent Risk Predictor of Advanced Atherosclerosis and Arterial Disease
S Kiechl, A Muigg, P Santer, M Mitterer, G Egger, M Oberhollenzer, F Oberhollenzer, A Mayr, A Gasperi, W Poewe, J Willeit
Circulation 1999
Antithrombotics
AC Uprichard, KP Gallagher
1999
Cleavage of Factor V at Arg 506 by Activated Protein C and the Expression of Anticoagulant Activity of Factor V
E Thorelli, RJ Kaufman, B Dahlbäck
Blood 1999
Activated Protein C Resistance: Effect of Platelet Activation, Platelet-Derived Microparticles, and Atherogenic Lipoproteins
J Taube, N McWilliam, R Luddington, CD Byrne, T Baglin
Blood 1999
A Reduced Sensitivity for Activated Protein C in the Absence of Factor V Leiden Increases the Risk of Venous Thrombosis
MC de Visser, FR Rosendaal, RM Bertina
Blood 1999
No Prognostic Importance of Resistance to Activated Protein C in Unstable Coronary Artery Disease Despite Signs of Thrombin Activation
Toss, Ernofsson, Wallentin, Seigbahn
Journal of Thrombosis and Thrombolysis 1999
EARLY LOSS OF RENAL TRANSPLANTS IN PATIENTS WITH THROMBOPHILIA
M Fischereder, P G??hring, H Schneeberger, P Lohse, KV Appen, W Samtleben, D Schl??ndorff, W Land
Transplantation 1998
Low risk of venous thrombosis in two families with combined type I plasminogen deficiency and factor V R506Q mutation
G Castaman, M Ruggeri, A Tosetto, F Rodeghiero
American Journal of Hematology 1998
The Role of Activated Protein C Resistance in the Pathogenesis of Venous Thrombosis
WC Hooper, BL Evatt
The American Journal of the Medical Sciences 1998
No Correlation between Activated Protein C Resistance and Free Flap Failures in 100 Consecutive Patients
B Arnljots, T Söderström, H Svensson
Plastic & Reconstructive Surgery 1998
Production of phospholipid antibodies in selected thrombophilic women differing in genotype at the 506 site of factor V
MI Bokarewa, K Bremme
European Journal of Haematology 1998
Activated protein C resistance in patients with peripheral vascular disease
ES Sampram, B Lindblad, B Dahlbäck
Journal of Vascular Surgery 1998
Changes of Resistance to Activated Protein C in The Course of Pregnancy and Prevalence of Factor V Mutation
S Mimuro, R Lahoud, L Beutler, B Trudinger
The Australian and New Zealand Journal of Obstetrics and Gynaecology 1998
Polymorphisms in the Coagulation Factor VII Gene and the Risk of Myocardial Infarction
L Iacoviello, AD Castelnuovo, P Knijff, A D'Orazio, C Amore, R Arboretti, C Kluft, MB Donati
New England Journal of Medicine 1998
Pulmonary Embolism
SZ Goldhaber
New England Journal of Medicine 1998
The Arg506Gln Mutation (FV Leiden) Among a Cohort of 4188 Unselected Danish Newborns
TB Larsen, JF Lassen, I Brandslund, L Byriel, GB Petersen, B Nørgaard-Pedersen
Thrombosis Research 1998
New DNA Diagnostic System for Detection of Factor V Leiden
LI Patrushev, ES Zykova, AL Kayushin, MD Korosteleva, AI Miroshnikov, IN Bokarew, SG Leont’ev, VM Koshkin, ES Severin
Thrombosis Research 1998
Evaluation of Role of Factor V Leiden Mutation in Fatal Pulmonary Thromboembolism
ST Dunn, S Trong
Thrombosis Research 1998
Effect of Anticoagulant Therapy on the Hypercoagulable State in Patients Carrying the Factor V Arg506Gln Mutation
TB Larsen, JF Lassen, BS Dahler-Eriksen, PH Petersen, I Brandslund
Thrombosis Research 1998
Guidelines for antithrombotic therapy in pediatric patients
M Andrew, AD Michelson, E Bovill, M Leaker, MP Massicotte
The Journal of Pediatrics 1998
Stroke in a Neonate Heterozygous for Factor V Leiden
PN MD, BJ MD, HM MD, GS MD, LR MD
Pediatric Neurology 1998
Thrombophilia and Activated Protein C Resistance
CH Selzman, TA Whitehill, WC Krupski
Annals of Vascular Surgery 1998
Activated protein C resistance and deficiencies of antithrombin III, protein C or protein S and the risk of thromboembolic disease in users of oral contraceptives
UH Winkler
The European Journal of Contraception and Reproductive Health Care 1998
Deep Venous Thrombosis in a Preterm Newborn of a Mother with Activated Protein C Resistance
Y Finkelstein, D Aloni, A Kimia, R Sommer, L Sirota
Clinical Pediatrics 1998
Klinische Angiologie
H Rieger, W Schoop
1998
Factor V Cambridge: A New Mutation (Arg306→Thr) Associated With Resistance to Activated Protein C
D Williamson, K Brown, R Luddington, C Baglin, T Baglin
Blood 1998
Platelet-Derived Factor Va/VaLeiden Cofactor Activities Are Sustained on the Surface of Activated Platelets Despite the Presence of Activated Protein C
RM Camire, M Kalafatis, P Simioni, A Girolami, PB Tracy
Blood 1998
The A20210 Allele of the Prothrombin Gene Is Frequently Associated With the Factor V Arg 506 to Gln Mutation But Not With Protein S Deficiency in Thrombophilic Families
B Zöller, PJ Svensson, B Dahlbäck, A Hillarp
Blood 1998
Ensuring Accurate Molecular Genetic Testing
M McGovern
Clinical chemistry 1998
Activated protein C resistance, thrombophilia, and inflammatory bowel disease
M A Heneghan, B Cleary, M Murray, T A O'Gorman, C F McCarthy
Digestive Diseases and Sciences 1998
Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis
Ferreira\u2010Gonzalez A, Fisher L, Lehman C, Langley M, Lofland D, Xia Q, Nguyen N, Modesto D, Willoughby J, Wilkinson D, Garrett C
Journal of Clinical Laboratory Analysis 1998
Detection of a common mutation in factor V gene responsible for resistance to activated protein C causing predisposition to thrombosis
A Ferreira-Gonzalez, LM Fisher, CM Lehman, MH Langley, DH Lofland, Q Xia, NX Nguyen, D Modesto, JB Willoughby, DS Wilkinson, CT Garrett
Journal of Clinical Laboratory Analysis 1997
Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis
O Thorarensen, S Ryan, J Hunter, DP Younkin
Annals of Neurology 1997
Prevalence of factor V Leiden mutation in various populations
FH Herrmann, M Koesling, W Schröder, R Altman, RJ Bonilla, S Lopaciuk, JL Perez-Requejo, JR Singh
Genetic Epidemiology 1997
Factor V Leiden (R506Q) and risk of venous thromboembolism: a case-control study based on the Spanish population
JM García-Gala, V Alvarez, CR Pinto, I Soto, MF Urgellés, MJ Menéndez, C Carracedo, C López-Larrea, E Coto
Clinical Genetics 1997
Inherited thrombotic disorders: An update
SR Florell, GM Rodgers
American Journal of Hematology 1997
Changes in activated protein C resistance during normal pregnancy
MC Walker, PR Garner, EJ Keely, GA Rock, MD Reis
American Journal of Obstetrics and Gynecology 1997
Activated protein C resistance and adverse pregnancy outcome
S Rotmensch, M Liberati, M Mittelmann, Z Ben-Rafael
American Journal of Obstetrics and Gynecology 1997
Preeclampsia is associated with a reduced response to activated protein C
C Lindoff, I Ingemarsson, G Martinsson, M Segelmark, H Thysell, B Åstedt
American Journal of Obstetrics and Gynecology 1997
Venous thrombosis: factor V G1691A genotyping related to APC resistance as measured by 2 methods
A Alderborn, A Siegbahn, C Wadelius
European Journal of Haematology 1997
ACTIVATED PROTEIN C RESISTANCE DUE TO A COMMON FACTOR V GENE MUTATION IS A MAJOR RISK FACTOR FOR VENOUS THROMBOSIS
BZ MD, AH PhD, EB MD, BD MD
Annual Review of Medicine 1997
Venous thrombosis after Caesarean section in a young woman with homozygous APC resistance and type I protein S deficiency
FD Biasiutti, B Stucki, M Solenthaler, A Tobler, M Furlan, B Lämmle
European Journal of Haematology 1997
Impact of activated protein C resistance on general vascular surgical patients
MC Donaldson, M Belkin, AD Whittemore, JA Mannick, JA Longtine, DM Dorfman
Journal of Vascular Surgery 1997
Activated protein C resistance in patients with central retinal vein occlusion
J Larsson, A Sellman, B Bauer
The British journal of ophthalmology 1997
Dural puncture and activated protein C resistance: risk factors for cerebral venous sinus thrombosis
E Wilder-Smith, I Kothbauer-Margreiter, B Lämmle, M Sturzenegger, C Ozdoba, SP Hauser
Journal of neurology, neurosurgery, and psychiatry 1997
Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis
AE Mahmoud, E Elias, N Beauchamp, JT Wilde
Gut 1997
Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease
OD Pedersen, J Gram, J Jespersen
Heart (British Cardiac Society) 1997
AN ALTERNATIVE METHOD FOR IDENTIFYING THE FACTOR V GENE LEIDEN MUTATION
K Lewandowski, M Rożek, K Zawilska, WT Markiewicz
Thrombosis Research 1997
EVALUATION OF A NEW CHRONOMETRIC ASSAY FOR FACTOR V LEIDEN - DEPENDENT APC RESISTANCE
M Gouault-Heilmann, C Leroy-Matheron
Thrombosis Research 1997
ACTIVATED PROTEIN C RESISTANCE CAUSED BY A COMMON FACTOR V MUTATION HAS A SINGLE ORIGIN
B Zöller, A Hillarp, B Dahlbäck
Thrombosis Research 1997
Activated protein C resistance caused by factor V gene mutation: Common coagulation defect in chronic venous leg ulcers?
D Peus, JA Heit, MR Pittelkow
Journal of the American Academy of Dermatology 1997
Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
D Grossman, PW Heald, C Wang, HM Rinder
Journal of the American Academy of Dermatology 1997
2 Congenital thrombophilia
ID Walker
Baillière's Clinical Obstetrics and Gynaecology 1997
Thrombosis prophylaxis after treatment during pregnancy
G Daskalakis, A Antsaklis, I Papageorgiou, S Michalas
European Journal of Obstetrics & Gynecology and Reproductive Biology 1997
Fibrinolysis in patients with the 1691 G→A mutation in factor V gene and history of deep vein thrombosis
M Stegnar, P Peternel, P Uhrin, T Cvelbar-Marinko, K Goršič-Tomažic, BR Binder
Fibrinolysis and Proteolysis 1997
Screening for Resistance to Activated Protein C and the Mutant Gene for Factor V:Q506 in Patients With Central Retinal Vein Occlusion
AK Vine, MM Samama
American Journal of Ophthalmology 1997
The inherited basis of venous thrombosis
RD Appleby, RJ Olds
Pathology 1997
Venous Thromboembolism in Heterozygotes for Factor V Leiden—The Second-Hit Hypothesis: A Report of Two Patients and a Review of the English-Language Literature
HD Pak, AL Perrotta
Clinical and Applied Thrombosis/Hemostasis 1997
State-of-the-Art Review: Activated Protein C Resistance: Clinical Implications
B Zöller, A Hillarp, B Dahlbäck
Clinical and Applied Thrombosis/Hemostasis 1997
Molecular Genetics of Factor V Leiden: Genetic Origins and Modern DNA-Based Detection Strategies
C Maher, C Wall, S Fanning
Seminars in cardiothoracic and vascular anesthesia 1997
Intra-Atrial Thrombosis and Homozygous Factor V Leiden Mutation
P Simioni, D Scalia, D Tormene, S Bongiovi, C Sardella, A Girolami
Clinical and Applied Thrombosis/Hemostasis 1997
Resistance to Activated Protein C and Legg-Perthes Disease:
CJ Glueck, G Brandt, R Gruppo, A Crawford, D Roy, T Tracy, D Stroop, P Wang, A Becker
Clinical Orthopaedics and Related Research® 1997
Familial thrombophilia: genetic risk factors and management
M Makris, F Rosendaal, F Preston
Journal of Internal Medicine 1997
Factor V Leiden and Thrombophilia
M Kalafatis, KG Mann
Arteriosclerosis, thrombosis, and vascular biology 1997
Resistance to activated protein C caused by the R 506 Q mutation in the gene for factor V is a common risk factor for venous thrombosis
B Dahlbäck
Journal of Internal Medicine 1997
Gene Transfer in the Cardiovascular System
KL March
1997
Human Protein C Receptor Is Present Primarily on Endothelium of Large Blood Vessels: Implications for the Control of the Protein C Pathway
Z Laszik, A Mitro, FB Taylor, G Ferrell, CT Esmon
Circulation 1997
Advances in Critical Care Testing
WF List, MM Müller, MJ McQueen
1997
The Carbohydrate Moiety of Factor V Modulates Inactivation by Activated Protein C
JA Fernández, TM Hackeng, K Kojima, JH Griffin
Blood 1997
Genetic and Phenotypic Analysis of a Large (122-Member) Protein S–Deficient Kindred Provides an Explanation for the Familial Coexistence of Type I and Type III Plasma Phenotypes
RE Simmonds, B Zöller, H Ireland, E Thompson, PG de Frutos, B Dahlbäck, DA Lane
Blood 1997
Human Factor Va 1 and Factor Va 2 : Properties in the Procoagulant and Anticoagulant Pathways
L Hoekema, GA Nicolaes, HC Hemker, G Tans, J Rosing
Biochemistry 1997
Population study of the G1691A mutation (R506% FV Leiden) in the human factor V gene that is associated with resistance to activated protein C
A Braun, B Müller, AA Rosche
Human Genetics 1996
Are we ready for factor V Leiden screening?
B Dahlbäck
The Lancet 1996
ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency
CN Yandava, DC Zappulla, BR Korf, EJ Neufeld
Journal of Clinical Laboratory Analysis 1996
Arterial and venous thrombosis in two Italian families with the factor V Arg506→ Gln mutation
B Montaruli, J Voorberg, G Tamponi, A Borchielli, G Muleo, A Pannocchia, JA Mourik, P Schinco
European Journal of Haematology 1996
Strikes in French public transport and resistance to activated protein C
V Eschwège, A Robert
The Lancet 1996
Molecular mechanisms of activated protein C resistance. Properties of factor V isolated from an individual with homozygosity for the Arg506 to Gln mutation in the factor V gene
C Aparicio, B Dahlbäck
Biochemical Journal 1996
An assessment of the comparative utility of functional and molecular level analyses in the investigation of patients with thrombophilia
B Clark, C Caine, EN McSweeney, BA McVerry, HC Gooi
Clinical molecular pathology 1996
Case 12-1996 : An 18-year-old woman with hepatomegaly and ascites
RC Cabot, RE Scully, EJ Mark, WF McNeely, SH Ebeling, KA Bauer, FM Graeme-Cook
New England Journal of Medicine 1996
Absence of factor V Leiden in the Japanese
T Ozawa, K Niiya, N Sakuragawa
Thrombosis Research 1996
FACTOR V LEIDEN INCREASES THE RISK OF THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
R Simantov, SK Lo, JE Salmon, LR Sammaritano, RL Silverstein
Thrombosis Research 1996
OLIGONUCLEOTIDE LIGATION ASSAY FOR DETECTION OF THE FACTOR V MUTATION (Arg506→Gln) CAUSING PROTEIN C RESISTANCE
JM Benson, DJ Phillips, BP Holloway, BL Evatt, WC Hooper
Thrombosis Research 1996
Indications and drugs for anticoagulation therapy in children
M Andrew
Thrombosis Research 1996
Resistance to activated protein C: role in venous and arterial thrombosis
J Emmerich, M Alhenc-Gelas, M Aiach, JN Fiessinger
Biomedicine & Pharmacotherapy 1996
Activated Protein C Resistance and Thrombosis
WL Nichols, JA Heit
Mayo Clinic Proceedings 1996
Activated protein C resistance as a basis for venous thrombosis
A Hillarp, B Zöller, B Dahlbäck
The American Journal of Medicine 1996
Neonatal purpura fulminans in association with factor V R506Q mutation
SW Pipe, AH Schmaier, WC Nichols, D Ginsburg, ME Bozynski, VP Castle
The Journal of Pediatrics 1996
Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
DR Hirsch, KM Mikkola, PW Marks, EA Fox, DM Dorfman, BM Ewenstein, SZ Goldhaber
American Heart Journal 1996
Influence of blood handling on determination of plasma resistance against activated protein C
OD Pedersen, J Sidelmann, J Gram, J Jespersen
Fibrinolysis 1996
Familial thrombophilia: Clinical and molecular analysis of Swedish families with inherited resistance to activated protein C or protein S deficiency
B Zöller
Scandinavian Journal of Clinical & Laboratory Investigation 1996
Resistance to activated protein C due to a factor V gene mutation
B Zöller, J Holm, B Dahlbäck
Trends in Cardiovascular Medicine 1996
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
A Bengtsson, B Zöller, PG Frutos, B Dahlbäck, G Sturfelt
Lupus 1996
Coagulation for Blood Bankers
JR Stubbs
Clinics in Laboratory Medicine 1996
Resistance to Activated Protein C and A Novel Factor V Gene Mutation
KV Voelkerding
Clinics in Laboratory Medicine 1996
Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine 506 →Glutamine Mutation
M Fisher, JA Fernández, SF Ameriso, D Xie, A Gruber, A Paganini-Hill, JH Griffin
Stroke; a journal of cerebral circulation 1996
Ischemic Stroke in the Elderly: Role of the Common Factor V Mutation Causing Resistance to Activated Protein C
RD Press, XY Liu, N Beamer, BM Coull
Stroke; a journal of cerebral circulation 1996
25. Hämophilie-Symposion Hamburg 1994
I Scharrer, W Schramm
1996
Recognition and management of the hypercoagulable states: A decade of change
SH Goodnight, TG DeLoughery, RD Press
Journal of Thrombosis and Thrombolysis 1996
Activated protein C and retinal vein occlusion
BJ Hunt
The British journal of ophthalmology 1996
Actuated protein C resistance: From phenotype to genotype and clinical practice
A Hillarp, B Dahlbäck, B Zöller
Blood Reviews 1995
A chromogenic assay for activated protein C resistance
K Varadi, B Moritz, H Lang, K Bauer, E Preston, I Peake, GE Rivard, B Keil, HP Schwarz
British Journal of Haematology 1995
Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives
M Hellgren, PJ Svensson, B Dahlbäch
American Journal of Obstetrics and Gynecology 1995
Coagulation assay with improved specificity to factor V mutants insensitive to activated protein C
M Kraus, N Zander, K Fickenscher
Thrombosis Research 1995
Diagnostic de résistance à la protéine C activée par test chronométrique et par biologie moléculaire
M Trossaërt, N Pourkiani, J Conard, MH Horellou, F Delers, MM Samama
La Revue de Médecine Interne 1995
Activated protein C resistance in a neonate with venous thrombosis
E Kodish, C Potter, NE Kirschbaum, PA Foster
The Journal of Pediatrics 1995
Le diagnostic biologique de la résistance à la protéine C activée
M Trossaërt, J Conard, MH Horellou, I Elalamy, MM Samama
Revue Française des Laboratoires 1995
Molecular Genetics of Venous Thromboembolism
B Dahlbäck
Annals of Medicine 1995
Antithrombotic Therapy in Children
AD Michelson, E Bovill, M Andrew
Chest 1995
Biochemical Prototype for Familial Thrombosis: A Study Combining a Functional Protein C Mutation and Factor V Leiden
M Kalafatis, D Lu, RM Bertina, GL Long, KG Mann
Arteriosclerosis, thrombosis, and vascular biology 1995
Factor V Leiden -- An Unselfish Gene?
KA Hajjar
New England Journal of Medicine 1994
The molecular genetics of familial venous thrombosis
DN Cooper
Blood Reviews 1991
Advances in Genetics
BH Bowman, F Yang, GS Adrian
Advances in genetics 1988

← Previous 1 2 3 … 11 12 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 policy sources
Referenced in 1 Wikipedia pages
Referenced in 1 clinical guideline sources
35 readers on Mendeley
See more details